The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Sertraline for the Treatment of Depression in Alzheimer Disease
Open accessAbstract
Objective Depression is common in Alzheimer disease (AD), and antidepressants are commonly used for its treatment, however, evidence for antidepressant efficacy in this population is lacking. The authors conducted a multicenter, randomized, placebo-controlled trial titled "Depression in Alzheimer's Disease-2" to assess the efficacy and tolerability of sertraline for depression in AD.Methods One hundred thirty-one participants from five U.S. medical centers with mild-to-moderate AD (Mini-Mental State Examination scores 10-26) and depression of AD were randomized to double-blinded treatment with sertraline (N = 67) or placebo (N = 64), with a target dosage of 100 mg daily. Efficacy was assessed using logistic regressions and mixed effects models in an intention-to-treat analysis with imputation of missing data. Principal outcome measures were modified Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change (mADCS-CGIC), change in Cornell Scale for Depression in Dementia (CSDD) scores, and remission defined by both mADCS-CGIC score <or=2 and CSDD score <or=6.Results mADCS-CGIC ratings (odd ratio [OR = 1.01], 95% confidence interval [CI]: 0.52-1.97, p = 0.98), CSDD scores (median difference at 12 weeks 1.2, 95% CI: 1.65-4.05, p = 0.41), and remission at 12 weeks of follow-up (OR = 2.06, 95% CI: 0.84-5.04, p = 0.11) did not differ between sertraline (N = 67) and placebo (N = 64). Sertraline-treated patients experienced more adverse events, most notably gastrointestinal and respiratory, than placebo-treated patients.Conclusion Sertraline did not demonstrate efficacy for the treatment depression symptoms in patients with AD. In addition, its use was associated with an increased incidence of adverse events. Thus, selective serotonin reuptake inhibitors may be of limited value for treating depression in patients with AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“(b) antidepressant medication causes severe neurological side effects, which reflect antidepressants interfering with brain function, possibly via altering neurotransmitter systems [29-31]”
From Risk analysis of use of different classes of antidepressants on subsequent dementia: A nationwide cohort study in Taiwan (2017) · cites this paper as [30]
Experimental — accuracy not yet measuredIn the citing paper
“While this method of drug discovery has the attractive feature of studying drugs with generally well-characterized safety profiles, it is inherently limited especially in terms of interpreting null results (Rosenberg et al., 2010).”
From Neuropsychiatric symptoms in Alzheimer's disease: what might be associated brain circuits? (2015) · cites this paper as Rosenberg et al., 2010
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
Intraclass correlations: Uses in assessing rater reliability.
Shrout, P. E., & Fleiss, J. L. (1979) · Psychological Bulletin · doi:10.1037/0033-2909.86.2.420 · Cited by 24,532
Multiple Imputation for Nonresponse in Surveys
Rubin, D. B. (1987) · Wiley Series in Probability and Statistics · doi:10.1002/9780470316696 · Cited by 20,701
Multiple imputation after 18+ years
Rubin, D. B. (1996) · Journal of the American Statistical Association · doi:10.1080/01621459.1996.10476908 · Cited by 4,072
Multiple Imputation After 18+ Years
Rubin, D. B. (1996) · Journal of the American Statistical Association · doi:10.2307/2291635 · Cited by 2,686
Cornell scale for depression in dementia
Alexopoulos, G. S., Abrams, R. C., Young, R. C., & Shamoian, C. A. (1988) · Biological Psychiatry · doi:10.1016/0006-3223(88)90038-8 · Cited by 2,678
Point and 5‐year period prevalence of neuropsychiatric symptoms in dementia: the Cache County Study
Steinberg, M., Shao, H., Zandi, P., Lyketsos, C. G., Welsh‐Bohmer, K. A., Norton, M. C., Breitner, J. C. S., Steffens, D. C., & Tschanz, J. T. (2008) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1858 · Cited by 780
Self-citationMultiple Imputation for Nonresponse in Surveys
Campion, W. M., & Rubin, D. B. (1989) · Journal of Marketing Research · doi:10.2307/3172772 · Cited by 775
Exercise Plus Behavioral Management in Patients With Alzheimer Disease
Teri, L. L., Gibbons, L. E., McCurry, S. M., Logsdon, R. G., Büchner, D. M., Barlow, W. E., Kukull, W. A., LaCroix, A. Z., McCormick, W. C., & Larson, E. B. (2003) · JAMA · doi:10.1001/jama.290.15.2015 · Cited by 765
Schneider, L., Olin, J. T., Doody, R. S., Clark, C. M., Morris, J. C., Reisberg, ., Schmitt, F. A., Grundman, M., Thomas, R. G., & Ferris, S. H. (1997) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-199700112-00004 · Cited by 646
Self-citation
Research works printed but not linked: 1
- Garre-Olmo, 2002, Carer's burden and depressive symptoms in patients with Alzheimer's disease. State after twelve months, Rev Neurol, 34, 601
Cited by
Sorted by citations
Dementia prevention, intervention, and care
Livingston, G., Sommerlad, A., Orgeta, V., Costafreda, S. G., Huntley, J., Ames, D., Ballard, C., Banerjee, S., Burns, A., Cohen-Mansfield, J., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31363-6 · Cited by 6,072
Self-citationMasters, C. L., Bateman, R., Blennow, K., Rowe, C. C., Sperling, R. A., & Cummings, J. L. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.56 · Cited by 1,853
Depression and risk of developing dementia
Byers, A. L., & Yaffe, K. (2011) · Nature Reviews Neurology · doi:10.1038/nrneurol.2011.60 · Cited by 1,265
Assessment and management of behavioral and psychological symptoms of dementia
Kales, H. C., Gitlin, L. N., & Lyketsos, C. G. (2015) · BMJ · doi:10.1136/bmj.h369 · Cited by 1,247
Self-citationNeuropsychiatric symptoms in Alzheimer's disease
Lyketsos, C. G., Carrillo, M. C., Ryan, J. M., Khachaturian, A. S., Trzepacz, P., Amatniek, J., Cedarbaum, J., Brashear, R., & Miller, D. S. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.05.2410 · Cited by 1,139
Self-citationCleare, A., Pariante, C., Young, A., Anderson, I., Christmas, D., Cowen, P., Dickens, C., Ferrier, I., Geddes, J., Gilbody, S., et al. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881115581093 · Cited by 759
Banerjee, S., Hellier, J., Dewey, M., Romeo, R., Ballard, C., Baldwin, R., Bentham, P., Fox, C., Holmes, C., Katona, C., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60830-1 · Cited by 532
World Alzheimer Report 2011 : The benefits of early diagnosis and intervention
Prince, M. J., Bryce, R., & Ferri, C. P. (2018) · Cited by 448
Neuropsychiatric signs and symptoms of Alzheimer's disease: New treatment paradigms
Lanctôt, K. L., Amatniek, J., Ancoli‐Israel, S., Arnold, S. E., Ballard, C., Cohen‐Mansfield, J., Ismail, Z., Lyketsos, C., Miller, D. S., Musiek, E., et al. (2017) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1016/j.trci.2017.07.001 · Cited by 395
Self-citationNeuropsychiatric symptoms in Alzheimer's disease: what might be associated brain circuits?
Rosenberg, P. B., Nowrangi, M. A., & Lyketsos, C. G. (2015) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2015.05.005 · Cited by 302
Self-citationNelson, J. C., & Devanand, D. P. (2011) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2011.03355.x · Cited by 284
Multimorbidity—older adults need health care that can count past one
Banerjee, S. (2014) · The Lancet · doi:10.1016/s0140-6736(14)61596-8 · Cited by 257
Banerjee, S., Hellier, J. M., Romeo, R., Dewey, M. E., Knapp, M. R. J., Ballard, C. G., Baldwin, R., Bentham, P., Fox, C., Holmes, C., et al. (2013) · Health Technology Assessment · doi:10.3310/hta17070 · Cited by 241
Trillo, L., Das, D., Hsieh, W., Medina, B., Moghadam, S., Lin, B., Dang, V., Sanchez, M. M., Miguel, Z. D., Ashford, J. W., et al. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.05.008 · Cited by 230
Orgeta, V., Tabet, N., Nilforooshan, R., & Howard, R. (2017) · Journal of Alzheimer's Disease · doi:10.3233/jad-161247 · Cited by 203
Szymkowicz, S. M., Gerlach, A., Homiack, D., & Taylor, W. D. (2023) · Translational Psychiatry · doi:10.1038/s41398-023-02464-9 · Cited by 234
Rosenberg, P. B., Lanctôt, K. L., Drye, L. T., Herrmann, N., Scherer, R. W., Bachman, D. L., Mintzer, J. E., & ADMET investigators (2013) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.12m08099 · Cited by 191
Self-citationAntidepressants for treating depression in dementia
Dudas, R., Malouf, R., McCleery, J., & Dening, T. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003944.pub2 · Cited by 175
Kok, R. M., Nolen, W. A., & Heeren, T. J. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.02.036 · Cited by 167
A common challenge in older adults: Classification, overlap, and therapy of depression and dementia
Leyhe, T., Reynolds, C. F., Melcher, T., Linnemann, C., Klöppel, S., Blennow, K., Zetterberg, H., Dubois, B., Lista, S., & Hampel, H. J. (2016) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2016.08.007 · Cited by 175
Depression in Alzheimer's Disease: Epidemiology, Mechanisms, and Management
Chi, S., Yu, J., Tan, M., & Tan, L. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-140324 · Cited by 173
Problem Adaptation Therapy for Older Adults With Major Depression and Cognitive Impairment
Kiosses, D. N., Ravdin, L., Gross, J. J., Raue, P. J., Kotbi, N., & Alexopoulos, G. S. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.1305 · Cited by 153
Watt, J. A., Goodarzi, Z., Veroniki, A. A., Nincic, V., Khan, P. A., Ghassemi, M., Lai, Y., Treister, V., Thompson, Y., Schneider, R., et al. (2021) · BMJ · doi:10.1136/bmj.n532 · Cited by 143
Diagnosis and treatment of depression and cognitive impairment in late life
Morimoto, S. S., Kanellopoulos, D., Manning, K. J., & Alexopoulos, G. S. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12669 · Cited by 150
Bergh, S., Selbaek, G., & Engedal, K. (2012) · BMJ · doi:10.1136/bmj.e1566 · Cited by 124
Behavioral and psychological symptoms in Alzheimer's dementia and vascular dementia
Deardorff, W. J., & Grossberg, G. T. (2019) · Handbook of clinical neurology · doi:10.1016/b978-0-444-64012-3.00002-2 · Cited by 133
Treatment for Alzheimer's disease
Fox, N. C., Belder, C. R. S., Ballard, C. G., Kales, H. C., Mummery, C. J., Caramelli, P., Ciccarelli, O., Frederiksen, K. S., Gómez‐Isla, T., Ismail, Z., et al. (2025) · The Lancet · doi:10.1016/s0140-6736(25)01329-7 · Cited by 137
Rosenberg, P. B., Mielke, M. M., Han, D., Leoutsakos, J. S., Lyketsos, C. G., Rabins, P. V., Zandi, P. P., Breitner, J. C. S., Norton, M. C., Welsh‐Bohmer, K. A., et al. (2012) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.3769 · Cited by 127
Self-citationDiagnosing and Treating Depression in Patients with Alzheimer’s Disease
Burke, A. D., Goldfarb, D., Bollam, P., & Khokher, S. (2019) · Neurology and Therapy · doi:10.1007/s40120-019-00148-5 · Cited by 115
Herrmann, N., Lanctôt, K. L., & Hogan, D. B. (2013) · Alzheimer s Research & Therapy · doi:10.1186/alzrt201 · Cited by 116
Pharmacological interventions for apathy in Alzheimer's disease
Ruthirakuhan, M. T., Herrmann, N., Abraham, E. H., Chan, S., & Lanctôt, K. L. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012197.pub2 · Cited by 113
The complex relationship between depression and dementia
Varghese, M., & Muliyala, K. (2010) · Annals of Indian Academy of Neurology · doi:10.4103/0972-2327.74248 · Cited by 119
Slowing the progression of Alzheimer’s disease; what works?
Nelson, L., & Tabet, N. (2015) · Ageing Research Reviews · doi:10.1016/j.arr.2015.07.002 · Cited by 117
Naltrexone for impulse control disorders in Parkinson disease
Papay, K., Xie, S. X., Stern, M., Hurtig, H. I., Siderowf, A. D., Duda, J. E., Minger, J., & Weintraub, D. A. (2014) · Neurology · doi:10.1212/wnl.0000000000000729 · Cited by 103
Self-citationIhl, R., Frölich, L., Winblad, B. G., Schneider, L. S. S., Burns, A. S., Möller, H., & WFSBP Task Force on Treatment Guidelines for Alzheimer's Disease and other Dementias (2011) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2010.538083 · Cited by 99
Self-citationDepression in Cognitive Impairment
Pellegrino, L. D., Peters, M. E., Lyketsos, C. G., & Marano, C. M. (2013) · Current Psychiatry Reports · doi:10.1007/s11920-013-0384-1 · Cited by 101
Self-citationSchneider, L. S. S., Frangakis, C., Drye, L. T., Devanand, D. P., Marano, C. M., Mintzer, J., Mulsant, B. H., Munro, C. A., Newell, J. A., Pawluczyk, S., et al. (2016) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.15050648 · Cited by 96
Self-citationSepehry, A. A., Lee, P. E., Hsiung, G. Y. R., Beattie, B. L., & Jacova, C. (2012) · Drugs & Aging · doi:10.1007/s40266-012-0012-5 · Cited by 94
Serotonergic Therapies for Cognitive Symptoms in Alzheimer’s Disease: Rationale and Current Status
Ramírez, M. J., Lai, M. K. P., Tordera, R. M., & Francis, P. T. (2014) · Drugs · doi:10.1007/s40265-014-0217-5 · Cited by 94
Depression in Alzheimer's Disease. Pathophysiology, Diagnosis, and Treatment
Modrego, P. J. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100153 · Cited by 87
What is the therapeutic value of antidepressants in dementia? A narrative review
Farina, N., Morrell, L., & Banerjee, S. (2016) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4566 · Cited by 87
Psychotropic use and associated neuropsychiatric symptoms among patients with dementia in the USA
Maust, D. T., Langa, K. M., Blow, F. C., & Kales, H. C. (2016) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4452 · Cited by 91
Symptomatic and Nonamyloid/Tau Based Pharmacologic Treatment for Alzheimer DiseasePreprint
Aisen, P. S. S., Cummings, J. L., & Schneider, L. S. (2011) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006395 · Cited by 83
Self-citationEsmaeili, M. H., Bahari, B., & Salari, A. (2018) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2018.01.001 · Cited by 81
Moderators of Outcome in Late-Life Depression: A Patient-Level Meta-Analysis
Nelson, J. C., Delucchi, K. L., & Schneider, L. S. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.12070927 · Cited by 80
Self-citationDepression associated with dementia
Gutzmann, H., & Qazi, A. (2015) · Zeitschrift für Gerontologie und Geriatrie · doi:10.1007/s00391-015-0898-8 · Cited by 84
Rabins, P. V., Rovner, B. W., Rummans, T. A., Schneider, L. S. S., & Tariot, P. N. (2017) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.15106 · Cited by 77
Self-citationQuintessential Risk Factors: Their Role in Promoting Cognitive Dysfunction and Alzheimer’s Disease
Daulatzai, M. A. (2012) · Neurochemical Research · doi:10.1007/s11064-012-0854-6 · Cited by 70
Advances in Management of Neuropsychiatric Syndromes in Neurodegenerative Diseases
Cummings, J. L., Ritter, A. R., & Rothenberg, K. G. (2019) · Current Psychiatry Reports · doi:10.1007/s11920-019-1058-4 · Cited by 72
Pharmacological treatment of dementia
Schwarz, S. T., Froelich, L., & Burns, A. S. (2012) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e328358e4f2 · Cited by 69
Then, C. K., Liu, K.-H., Liao, M.-H., Chung, K., Wang, J., & Shen, S. (2017) · Oncotarget · doi:10.18632/oncotarget.23302 · Cited by 61
Harrison, S. L., Cations, M., Jessop, T., Hilmer, S. N., Sawan, M. J., & Brodaty, H. (2018) · Drugs & Aging · doi:10.1007/s40266-018-0623-6 · Cited by 63
Amani, M., Shokouhi, G., & Salari, A. (2018) · Psychopharmacology · doi:10.1007/s00213-018-5137-8 · Cited by 63
Antidepressants for Depression in Patients with Dementia: A Review of the Literature
Leong, C. (2014) · The Consultant Pharmacist · doi:10.4140/tcp.n.2014.254 · Cited by 59
Drye, L. T., Martin, B. K., Frangakis, C., Meinert, C. L., Mintzer, J. E., Munro, C. A., Porsteinsson, A. P., Rabins, P. V., Rosenberg, P. B., Schneider, L. S. S., et al. (2010) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2565 · Cited by 58
Self-citationMolecular Basis of Late-Life Depression
Kuo, C.-Y., Lin, C., & Lane, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147421 · Cited by 62
Jennings, A., Foley, T., Walsh, K. A., Coffey, A., Browne, J. P., & Bradley, C. (2018) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4918 · Cited by 62
Spalletta, G., Caltagirone, C., Girardi, P., Gianni, W., Casini, A. R., & Palmer, K. (2012) · Psychiatry Research · doi:10.1016/j.psychres.2011.11.018 · Cited by 55
Epidemiology, Assessment, and Treatment of Dementia
Nowrangi, M. A., Rao, V., & Lyketsos, C. G. (2011) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2011.02.004 · Cited by 58
Self-citationTreatment of behavioral and psychological symptoms of dementia: a systematic review
Preuss, U. W., Wong, J., & Koller, G. (2016) · Psychiatria Polska · doi:10.12740/pp/64477 · Cited by 59
Khundakar, A. A., & Thomas, A. J. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-148003 · Cited by 53
He, Y., Li, H., Huang, J., Huang, S., Bai, Y., Li, Y., & Huang, W. (2021) · Journal of Psychopharmacology · doi:10.1177/02698811211030181 · Cited by 52
Depression in Alzheimer’s Disease: An Alternative Role for Selective Serotonin Reuptake Inhibitors?
Elsworthy, R. J., & Aldred, S. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-180780 · Cited by 49
Citalopram for agitation in Alzheimer's disease: Design and methods
Drye, L. T., Ismail, Z., Porsteinsson, A. P., Rosenberg, P. B., Weintraub, D., Marano, C., Pelton, G., Frangakis, C., Rabins, P. V., Munro, C. A., et al. (2012) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.01.007 · Cited by 52
Self-citationLozupone, M., Montagna, M. L., D’Urso, F., Piccininni, C., Sardone, R., Dibello, V., Giannelli, G., Solfrizzi, V., Greco, A., Daniele, A., et al. (2018) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2018.1471136 · Cited by 50
Cognitive Outcomes After Sertaline Treatment in Patients With Depression of Alzheimer Disease
Munro, C. A., Longmire, C. F., Drye, L. T., Martin, B. K., Frangakis, C. E., Meinert, C. L., Mintzer, J. E., Porsteinsson, A. P., Rabins, P. V., Rosenberg, P. B., et al. (2012) · The American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e31826ce4c5 · Cited by 49
Self-citationPharmacotherapeutic Management of Dementia Across Settings of Care
Rattinger, G. B., Burcu, M., Dutcher, S. K., Chhabra, P. T., Rosenberg, P. B., Simoni‐Wastila, L., Franey, C. S., Walker, L. D., & Zuckerman, I. H. (2013) · Journal of the American Geriatrics Society · doi:10.1111/jgs.12210 · Cited by 45
Self-citationThe Possible Application of Ketamine in the Treatment of Depression in Alzheimer’s Disease
Mohammad Shehata, I., Masood, W., Nemr, N., Anderson, A., Bhusal, K., Edinoff, A. N., Cornett, E. M., Kaye, A. M., & Kaye, A. D. (2022) · Neurology International · doi:10.3390/neurolint14020025 · Cited by 41
How do the phq‐2, the phq‐9 perform in aging services clients with cognitive impairment?
Boyle, L. L., Richardson, T. M., He, H., Xia, Y., Tu, X. M., Boustani, M. A., & Conwell, Y. (2010) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2632 · Cited by 40
Soto, M. E., Andrieu, S., Nourhashémi, F., Ousset, P., Ballard, C. G., Robert, P. H., Vellas, B. J., Lyketsos, C. G., & Rosenberg, P. B. (2014) · International Psychogeriatrics · doi:10.1017/s1041610214001720 · Cited by 41
Self-citationInterventions for Neuropsychiatric Symptoms in Neurocognitive Impairment Due to Alzheimer’s Disease
McClam, T. D., Marano, C. M., Rosenberg, P. B., & Lyketsos, C. G. (2015) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000097 · Cited by 45
Self-citationZhang, Q., Yang, C., Liu, T., Liu, L., Li, F., Cai, Y., Lv, K., Li, X., Gao, J., Sun, D., et al. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.12.021 · Cited by 40
Management of Depression in Patients with Dementia: Is Pharmacological Treatment Justified?
Ford, A. H., & Almeida, O. P. (2017) · Drugs & Aging · doi:10.1007/s40266-016-0434-6 · Cited by 40
Molecular imaging of neuropsychiatric symptoms in Alzheimer's and Parkinson's disease
Hirao, K., Pontone, G. M., & Smith, G. S. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.11.010 · Cited by 38
Bingham, K. S., Flint, A. J., & Mulsant, B. H. (2019) · Current Psychiatry Reports · doi:10.1007/s11920-019-1047-7 · Cited by 37
Walsh, K. A., O’Regan, N., Byrne, S., Browne, J. P., Meagher, D. J., & Timmons, S. (2016) · International Psychogeriatrics · doi:10.1017/s1041610216001307 · Cited by 38
Treatment Options for Agitation in Dementia
Ringman, J. M., & Schneider, L. S. S. (2019) · Current Treatment Options in Neurology · doi:10.1007/s11940-019-0572-3 · Cited by 38
Self-citationErdal, A., Flo, E., Aarsland, D., Ballard, C. G., Daltveit, D. S., & Husebo, B. S. (2018) · Drugs & Aging · doi:10.1007/s40266-018-0546-2 · Cited by 40
Then, C.-K., Chi, N.-F., Chung, K.-H., Kuo, L., Liu, K.-H., Hu, C.-J., Shen, S.-C., & Lin, Y.-K. (2017) · PLOS ONE · doi:10.1371/journal.pone.0175187 · Cited by 35
Group reminiscence therapy for adults with dementia: a review
Blake, M. (2013) · British Journal of Community Nursing · doi:10.12968/bjcn.2013.18.5.228 · Cited by 34
Kiosses, D. N., Rosenberg, P. B., McGovern, A. R., Fonzetti, P., Zaydens, H., & Alexopoulos, G. S. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150200 · Cited by 34
Self-citationEmerging treatments for the behavioral and psychological symptoms of dementia
Anand, A., Khurana, P., Chawla, J. S., Sharma, N., & Khurana, N. (2017) · CNS Spectrums · doi:10.1017/s1092852917000530 · Cited by 36
Frontiers in Alzheimer’s disease therapeutics
Stone, J. G., Casadesús, G., Rothenberg, K. G., Siedlak, S. L., Wang, X., Zhu, X., Perry, G. L., Castellani, R. J., & Smith, M. A. (2010) · Therapeutic Advances in Chronic Disease · doi:10.1177/2040622310382817 · Cited by 32
Management of Late-Life Depression
Nelson, J. C. (2018) · Handbook of experimental pharmacology · doi:10.1007/164_2018_170 · Cited by 37
Psychedelics as Novel Therapeutics in Alzheimer’s Disease: Rationale and Potential Mechanisms
Garcia‐Romeu, A., Darcy, S., Jackson, H., White, T., & Rosenberg, P. B. (2021) · Current topics in behavioral neurosciences · doi:10.1007/7854_2021_267 · Cited by 33
Self-citationClinicopathological correlates of depression in early Alzheimer's disease in the NACC
McCutcheon, S. T., Han, D., Troncoso, J., Koliatsos, V. E., Albert, M., Lyketsos, C. G., & Leoutsakos, J. S. (2016) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4435 · Cited by 29
Self-citationAntidepressant Prescribing Patterns in the Nursing Home: Second-Generation Issues Revisited
Shah, S. N., Schoenbachler, B., Streim, J. E., & Meeks, S. (2011) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2011.09.004 · Cited by 31
Change in agitation in Alzheimer's disease in the placebo arm of a nine-week controlled trial
Rosenberg, P. B., Drye, L. T., Porsteinsson, A. P., Pollock, B. G., Devanand, D. P., Frangakis, C., Ismail, Z., Marano, C., Meinert, C. L., Mintzer, J. E., et al. (2015) · International Psychogeriatrics · doi:10.1017/s1041610215001106 · Cited by 28
Self-citationCognitive and Neuropsychiatric Impairments in Alzheimer's Disease: Current Treatment Strategies
Borisovskaya, A., Pascualy, M., & Soo Borson, B. (2014) · Current Psychiatry Reports · doi:10.1007/s11920-014-0470-z · Cited by 29
Jeong, H. W., Yoon, K. H., Lee, C. H., Moon, Y. S., & Kim, D. H. (2022) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2022.20.2.311 · Cited by 26
Antidepressiva zur Behandlung der Depression bei Palliativpatienten
Ujeyl, M., & Müller-Oerlinghausen, B. (2012) · Der Schmerz · doi:10.1007/s00482-012-1221-x · Cited by 26
Aarskog, N. K., Hunskår, I., & Bruvik, F. (2019) · Physical & Occupational Therapy In Geriatrics · doi:10.1080/02703181.2019.1613466 · Cited by 27
Taylor, W. D., Boyd, B. D., Elson, D. M., Andrews, P., Albert, K. M., Vega, J. N., NEWHOUSE, P. A., Woodward, N. D., Kang, H., & Shokouhi, S. (2020) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2020.09.019 · Cited by 27
Curran, E. M., & Loi, S. M. (2013) · The Medical Journal of Australia · doi:10.5694/mja12.10567 · Cited by 25
Review of treatment for late-life depression
Allan, C. L., & Ebmeier, K. P. (2013) · Advances in Psychiatric Treatment · doi:10.1192/apt.bp.112.010835 · Cited by 25
Oh, E. S., Rosenberg, P. B., Rattinger, G. B., Stuart, E. A., Lyketsos, C. G., & Leoutsakos, J. (2020) · Journal of the American Geriatrics Society · doi:10.1111/jgs.16970 · Cited by 24
Self-citationBeyond Memory: A Focus on the Other Neuropsychiatric Symptoms of Dementia
Peters, M. E., & Lyketsos, C. G. (2015) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2014.11.002 · Cited by 24
Self-citationConverged avenues: depression and Alzheimer’s disease– shared pathophysiology and novel therapeutics
Bajaj, S., & Mahesh, R. (2024) · Molecular Biology Reports · doi:10.1007/s11033-023-09170-1 · Cited by 25
Lee, J. H., Koh, S. Q., Guadagna, S., Francis, P. T., Esiri, M. M., Chen, C., Wong, P. T. ‐., Dawe, G. S., & Lai, M. K. P. (2015) · Psychopharmacology · doi:10.1007/s00213-015-4131-7 · Cited by 23
Zhang, J., Zheng, X., & Zhao, Z. (2023) · BMC Neurology · doi:10.1186/s12883-023-03191-w · Cited by 25
Metadata
- Authors
- Rosenberg, P. B., Martin, B. K., Frangakis, C., Mintzer, J. E., Weintraub, D., Porsteinsson, A. P., Schneider, L. S., Rabins, P. V., Munro, C. A., Meinert, C. L., Lyketsos, C. G., & Drye, L. T.
- Affiliations
- Johns Hopkins University (US)
- Medical University of South Carolina (US)
- Mental Illness Research, Education and Clinical Centers (US)
- University of Rochester Medicine (US)
- University of Southern California (US)
- Corresponding author
- Rosenberg, Paul B.
- ORCID
- Venue
- The American Journal of Geriatric Psychiatry
- Publisher
- Elsevier BV
- Published
- 2010-02
- Volume
- 18
- Issue
- 2
- Pages
- 136-145
- ISSN
- 1064-7481 (ISSN-L)
- PMC
- PMC2842121
- OpenAlex
- W1983522355
- Cited by
- 250
- References
- 36
- Citations by year
- 2026: 7 · 2025: 10 · 2024: 14 · 2023: 5 · 2022: 14 · 2021: 8 · 2020: 9 · 2019: 14 · 2018: 13 · 2017: 14 · 2016: 11 · 2015: 21 · 2014: 21 · 2013: 24 · 2012: 24
- FWCI
- 19.46
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- American Journal of Geriatric Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (5u01mh068014-05, 5u01mh066176-05, 5u01mh066174-05, 5u01mh066177-05, 5u01mh066175-05)
- National Institute on Aging (K08AG029157, P50AG005142, P50AG005146)
- National Institute of Mental Health (U01 MH068014, U01 MH066174, 1U01MH066175, 1U01MH068014, U01MH066177, 1U01MH066177, 1U01MH066176, U01 MH066175, 1U01MH066174, U01 MH066176, U01MH066136)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- sertraline, Alzheimer's disease, depression, selective serotonin reuptake inhibitors, antidepressant efficacy, adverse events, depression remission, Cornell Scale for Depression in Dementia, mild to moderate dementia
- MeSH terms
- Assessment of Medication Adherence, Aged, Alzheimer Disease, Depression, Double-Blind Method, Female, Humans, Male, Patient Dropouts, Placebos, Treatment Outcome, Drug Monitoring, Selective Serotonin Reuptake Inhibitors, Sertraline, Medication Adherence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
